JACKLYN CHAVEZ: Open Payments
NPI 1699149153 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 48 payments from 14 companies in 2025. Trend: 2023 $1,293 · 2024 $919 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 14 | $290 |
| AstraZeneca Pharmaceuticals LP | 10 | $184 |
| Genmab U.S., Inc. | 4 | $106 |
| ABBVIE INC. | 4 | $91 |
| Astellas Pharma US Inc | 3 | $64 |
| Eisai Inc. | 3 | $63 |
| Sandoz Inc. | 1 | $36 |
| Caris MPI, Inc. | 2 | $34 |
| Tempus AI, Inc | 2 | $33 |
| pharmaand GmbH | 1 | $23 |
Products named: LYNPARZA, KEYTRUDA, Tivdak, ELAHERE, Veozah, Lenvima, MI CANCER SEEK, XT CDX.
Industry payments across NM — which companies pay providers there.
